Deinove

Latest news

09.07.2019

Issuance of notes convertible into new shares for a maximum amount of €15M. Issuance of a first €2.2 million tranche

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...

24.06.2019

DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019

Major Steven Zumbrun (USAMRIID [1] , U.S. Department of Defense) presented data on the in vitro...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

More info

In the Medias

30.04.2019

Labiotech.eu | Life at its Limits: Meet the Extremophiles Being Embraced by the Biotech Industry

French biotech Deinove has an enviable collection of thousands of species of rare microbes that the company has been collecting since it...

19.03.2019

Arte | Antibiotiques, la fin du miracle ?

Le XXIe siècle marquera-t-il la fin de l’ère des antibiotiques, ramenant la médecine deux cents ans en arrière ? Malgré leurs efforts, les...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias